Clinical Trial Update: Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating antiplatelet therapy in patients undergoing transcatheter aortic valve implantation (TAVI).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease
• Bleeding
• Myocardial Infarction
• Stroke

Snippet

Sponsor: St. Antonius Hospital | Conditions: Aortic Valve Disease, Myocardial Infarction | Phase 4 | Status: COMPLETED